BD completes Carmel Pharma acquisition
FRANKLIN LAKES, N.J. — Becton, Dickinson and Co. now owns the manufacturer of the PhaSeal system.
BD said it has completed its acquisition of Sweden-based Carmel Pharma. Through the deal, BD now owns Carmel’s PhaSeal, a leading closed-system drug transfer device for the safe handling of hazardous drugs that are packaged in vials.
"Carmel Pharma is a leader in an early-stage market with significant long-term growth potential," BD Medical medical surgical systems president Alberto Mas said. "We’re excited to begin moving forward to address the critically important issue of hazardous drug exposure to healthcare providers by raising awareness, driving advocacy efforts, developing pharmacy and nursing relationships, and expanding market reach around the world for this product category."
Hospira expands board of directors
LAKE FOREST, Ill. — Hospira has appointed Abbott executive William Dempsey to its board.
Dempsey, who spent more than two decades at Abbott, most recently as EVP global pharmaceuticals for the drug maker.
The addition of Dempsey expands Hospira’s board to 11 directors, nine of whom are independent.
At-home skin care devices is a booming market, says Kline report
PARSIPPANY, N.J. — At-home skin care devices are expected to be the next billion-dollar market, according to a recently published report by consulting and research firm Kline & Co.
In the "At-home Skin Care Devices 2011: U.S. Market Analysis and Opportunities" report, Kline pegs the market at close to $1 billion at the retail level for 2011, with exceptional growth expected for the next five years. Kline’s report is the first of its kind to take an in-depth look at the market for this emerging class of power-operated devices designed for acne elimination, anti-aging treatment and daily cleansing.
“We knew this market was really taking off, but even we were shocked by its sheer size,” stated Karen Doskow, industry manager for Consumer Products at Kline. “Clearly, these devices are finding a very receptive and growing audience of savvy consumers looking to save time and money by avoiding regular trips to the doctor for those in-office procedures that were once commonplace in more robust economic times.”
With more consumers staying at home, either due to job losses or by virtue of the work-at-home/telecommuting trend, Doskow said the direct sales channel — which includes home shopping networks, infomercials and e-commerce — is the primary means of distribution, with about 60% of the total market share.
While sonic cleansing products, led by Clarisonic, top the list as the highest growth segment, acne treatment devices are the fastest-growing. Meanwhile, anti-aging devices are expected to grow by 50% this year alone, benefiting from consumers’ demand for products to reduce the appearance of fine lines, wrinkles and age spots. Kline’s recent Professional Skin Care research revealed that anti-aging is the No. 1 skin care concern for consumers, with topical product sales in this category comprising more than 40% of the market.
“This dynamic provides a perfect opportunity for device and topical product manufacturers to pair their products together to meet consumers’ anti-aging needs,” Doskow added.
"At-home Skin Care Devices 2011: U.S. Market Analysis and Opportunities" also points to strong opportunities for manufacturers to develop mass-market product options for price-sensitive consumers and to diversify their product lines to appeal to a wide range of age groups, from teens to mature consumers.